Allena Pharmaceuticals, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Allena Pharmaceuticals, Inc. is a Newton, Massachusetts-based biotechnology company focused on developing first-in-class oral enzyme therapies for rare and severe kidney-related metabolic disorders. Its approach uses non-absorbed enzymes delivered orally to the GI tract to degrade metabolites such as oxalate and urate, reducing their levels in plasma and urine and aiming to lessen kidney stone formation and progression of kidney disease. The company’s target customers are patients with these rare metabolic kidney conditions and the clinicians who treat them. It operates as a small to mid-sized biotech company pursuing development and potential commercialization of enzyme therapies. Notable governance and pipeline updates include the 2021 addition of Mark J. Fitzpatrick to the board and the first-in-human study of ALLN-346.